AION — Aion Therapeutic Balance Sheet
0.000.00%
Last trade - 00:00- CA$8.23m
- CA$9.92m
Annual balance sheet for Aion Therapeutic, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.62 | 0.613 | 0.24 | 0 | 0 |
| Net Total Receivables | 0.32 | 0.072 | 0 | 0.142 | 0.197 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.99 | 0.746 | 0.475 | 0.15 | 0.198 |
| Net Property, Plant And Equipment | 2.05 | 2.53 | 0.564 | 0 | — |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4.11 | 3.34 | 1.6 | 0.15 | 0.211 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.462 | 0.479 | 1.21 | 2.56 | 2.94 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.47 | 1.2 | 1.21 | 2.56 | 2.94 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 2.64 | 2.13 | 0.397 | -2.41 | -2.73 |
| Total Liabilities & Shareholders' Equity | 4.11 | 3.34 | 1.6 | 0.15 | 0.211 |
| Total Common Shares Outstanding |